Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-264

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-264-90 (Image 03)

Label for Atorvastatin Calcium 40 mg film-coated tablets by Proficient Rx LP. The label indicates a 90-count package of white, elliptical tablets, debossed with 'RX 829'. Manufactured by Sun Pharmaceutical Industries Limited, Mohali, India, with storage instructions and standard medication warnings. Includes NDC 71205-264-90 and batch information placeholders.*

FDA Label Image

Structure (Image 05)

Chemical structure of Atorvastatin Calcium showing the molecular arrangement including phenyl groups, fluorophenyl, hydroxyl groups, and calcium ion complexation as dihydrate form.*

FDA Label Image

Figure1 (Image 06)

A line chart showing the cumulative incidence (%) over 3.5 years comparing Atorvastatin and Placebo. The chart features two lines: a solid line representing Atorvastatin and a dashed line representing Placebo. The Atorvastatin group shows consistently lower cumulative incidence than the Placebo group.*

FDA Label Image

Figure 2 (Image 07)

A line chart comparing cumulative hazard percentages over time for Atorvastatin versus placebo groups, tracking time to first primary endpoint through four years of follow-up. The chart shows lower cumulative hazard in the Atorvastatin group with hazard ratio and statistical data included.*

FDA Label Image

Figure 3 (Image 08)

A Kaplan-Meier curve graph comparing the percentage of subjects experiencing a major cardiovascular event over time for Atorvastatin 10 mg versus Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph indicates a lower event rate for the 80 mg dose compared to the 10 mg dose, with a hazard ratio of 0.78 (95% CI 0.69-0.89) and a p-value of 0.0002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.